Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7QHG

LIM domain kinase 2 (LIMK2) in complex with TH-470

Summary for 7QHG
Entry DOI10.2210/pdb7qhg/pdb
DescriptorLIM domain kinase 2, 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide, 1,2-ETHANEDIOL, ... (4 entities in total)
Functional Keywordskinase, type-2 inhibitor, actin dynamics, cfl-1, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight71121.21
Authors
Mathea, S.,Salah, E.,Hanke, T.,Knapp, S. (deposition date: 2021-12-12, release date: 2021-12-22, Last modification date: 2024-01-31)
Primary citationHanke, T.,Mathea, S.,Woortman, J.,Salah, E.,Berger, B.T.,Tumber, A.,Kashima, R.,Hata, A.,Kuster, B.,Muller, S.,Knapp, S.
Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes.
J.Med.Chem., 65:13264-13287, 2022
Cited by
PubMed Abstract: LIMKs are important regulators of actin and microtubule dynamics, and they play essential roles in many cellular processes. Deregulation of LIMKs has been linked to the development of diverse diseases, including cancers and cognitive disabilities, but well-characterized inhibitors known as chemical probes are still lacking. Here, we report the characterization of three highly selective LIMK1/2 inhibitors covering all canonical binding modes (type I/II/III) and the structure-based design of the type II/III inhibitors. Characterization of these chemical probes revealed a low nanomolar affinity for LIMK1/2, and all inhibitors (; type I), (; type II), and (; type III) showed excellent selectivity in a comprehensive scanMAX kinase selectivity panel. Phosphoproteomics revealed remarkable differences between type I and type II inhibitors compared with the allosteric inhibitor . In phenotypic assays such as neurite outgrowth models of fragile X-chromosome, showed promising activity, suggesting the potential application of allosteric LIMK inhibitors treating this orphan disease.
PubMed: 36136092
DOI: 10.1021/acs.jmedchem.2c01106
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon